Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction

NCT01374321 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myocardial Infarctus

Interventions

DRUG: TRO40303
DRUG: Placebo

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]